MedTrace Logo

Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer

NCT05722847 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2025-05-25

No results posted yet for this study

Summary

This study explores whether supportive care interventions that might reduce rehospitalization could be implemented and feasible, in subjects within a high-risk group of subjects with newly diagnosed hospitalized advanced lung cancer (ALC).

This study screened 50 subjects from health records and consented to 15 of these screened subjects. These 15 subjects responded to PRO questionnaires.

Conditions

Sponsors & Collaborators

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Emily Ray, MD · Lineberger Comprehensive Cancer Center, The University of North Carolina Chapel Hill

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-14
Primary Completion
2025-01-05
Completion
2025-05-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05722847 on ClinicalTrials.gov